Residency · Residency · Preventive Medicine

Neglected Tropical Diseases: Prevention and Elimination Strategies

Introduction and Scope

Neglected tropical diseases (NTDs) are a group of 21 conditions recognized by WHO that disproportionately affect populations living in poverty in tropical and subtropical regions. NTDs affect more than 1.6 billion people worldwide, causing significant morbidity, disability, and socioeconomic loss. These diseases are termed "neglected" because they receive disproportionately low funding relative to their disease burden and primarily affect marginalized populations with limited political voice. The WHO NTD Roadmap 2021-2030 sets targets for the control, elimination, or eradication of 20 diseases and disease groups.

Classification and Epidemiology

Preventive Chemotherapy NTDs

Lymphatic filariasis: Caused by Wuchereria bancrofti, Brugia malayi, and B. timori; transmitted by mosquitoes; affects approximately 51 million people. Onchocerciasis (river blindness): Caused by Onchocerca volvulus; transmitted by blackflies (Simulium spp.); second leading infectious cause of blindness. Schistosomiasis: Caused by Schistosoma species; transmitted through freshwater snails; affects approximately 240 million people. Soil-transmitted helminthiases: Ascaris lumbricoides, Trichuris trichiura, and hookworms (Necator americanus, Ancylostoma duodenale); affect over 1.5 billion people. Trachoma: Caused by Chlamydia trachomatis; leading infectious cause of blindness; targeted for elimination by 2030.

Case Management NTDs

Visceral leishmaniasis (kala-azar): Caused by Leishmania donovani/infantum; fatal if untreated; 50,000-90,000 new cases annually. Chagas disease: Caused by Trypanosoma cruzi; affects approximately 6-7 million people, primarily in Latin America. Human African trypanosomiasis (sleeping sickness): Caused by T. brucei gambiense and rhodesiense; targeted for elimination as a public health problem. Leprosy (Hansen disease): Caused by Mycobacterium leprae; approximately 200,000 new cases annually; curable with multidrug therapy. Buruli ulcer: Caused by Mycobacterium ulcerans; debilitating skin disease prevalent in West Africa.

<image>World map showing the geographic overlap and distribution of the major neglected tropical diseases, with color-coded regions indicating areas where multiple NTDs are co-endemic, highlighting sub-Saharan Africa, South Asia, and Latin America</image>

Prevention and Control Strategies

Mass Drug Administration (MDA)

MDA is the cornerstone strategy for preventive chemotherapy NTDs, delivering safe, effective, and donated medicines to entire at-risk populations. The SAFE strategy for trachoma: Surgery for trichiasis, Antibiotics (azithromycin MDA), Facial cleanliness, Environmental improvement. Ivermectin-based MDA for onchocerciasis and lymphatic filariasis, often combined with albendazole or DEC (diethylcarbamazine) Triple-drug therapy (IDA): Ivermectin + DEC + albendazole accelerates lymphatic filariasis elimination where onchocerciasis is not co-endemic. School-based deworming programs target soil-transmitted helminths and schistosomiasis using albendazole/mebendazole and praziquantel.

Vector Control

Integrated vector management (IVM) addresses multiple NTDs simultaneously through environmental modification, biological control, and targeted insecticide use. Indoor residual spraying and insecticide-treated nets target vectors for leishmaniasis and Chagas disease. Tiny Targets: Insecticide-treated blue cloth targets reduce tsetse fly populations for sleeping sickness control. Housing improvements (plastering walls, replacing thatched roofs) reduce triatomine bug infestation for Chagas disease prevention.

Water, Sanitation, and Hygiene (WASH)

Access to safe water and improved sanitation is fundamental to preventing soil-transmitted helminths, schistosomiasis, and trachoma. WASH interventions reduce transmission of guinea worm (dracunculiasis), which is on the verge of eradication. Integration of NTD control with WASH programming maximizes impact and sustainability.

<image>Diagram illustrating the five key NTD intervention strategies: mass drug administration, vector control, WASH improvements, veterinary public health (One Health), and morbidity management, showing how they interconnect to break transmission cycles</image>

Elimination and Eradication Progress

Dracunculiasis (guinea worm): Reduced from 3.5 million cases in 1986 to fewer than 15 cases annually; targeted for eradication. Lymphatic filariasis: 17 countries have been validated for elimination as a public health problem as of 2023. Trachoma: 18 countries validated for elimination; global prevalence reduced by 90% since 2002. Onchocerciasis: Eliminated from 4 of 6 endemic countries in the Americas; verification ongoing in Africa. Human African trypanosomiasis: Cases reduced from 37,000 reported in 1998 to fewer than 1,000 annually.

Challenges and Emerging Issues

Co-endemicity requires integrated approaches; many populations face simultaneous burden from multiple NTDs. Drug resistance is a growing concern, particularly for soil-transmitted helminths (benzimidazole resistance) Sustainability of MDA programs depends on health system strengthening and domestic financing. Climate change may alter vector habitats and expand the geographic range of several NTDs. COVID-19 caused significant disruption to MDA campaigns, surveillance, and case management. Post-elimination surveillance is critical to prevent resurgence.

The Role of Preventive Medicine in NTD Control

Preventive medicine physicians can contribute to NTD programs through epidemiological surveillance, program evaluation, and health systems research. Understanding NTD epidemiology is essential for physicians serving immigrant and refugee populations in non-endemic countries. Screening protocols for Chagas disease, strongyloidiasis, and schistosomiasis should be implemented for at-risk migrants.

<image>Lifecycle diagram of Schistosoma species showing the human host, cercariae release from freshwater snails, skin penetration during water contact, adult worm migration to mesenteric or vesical venous plexuses, egg deposition, and miracidia hatching in freshwater, with intervention points marked at each stage</image>

Key Clinical Pearls

NTDs cluster in populations experiencing poverty, poor sanitation, and limited healthcare access, making them both indicators and drivers of health inequity. MDA programs rely on donated drugs from pharmaceutical companies (e.g., Merck's ivermectin, Pfizer's azithromycin), representing one of the largest public-private partnerships in global health. Screening for Strongyloides stercoralis is critical before immunosuppression (especially corticosteroids), as hyperinfection syndrome carries mortality rates exceeding 70%. Chagas disease affects an estimated 300,000 people in the United States, most undiagnosed, making it a domestic as well as global health concern.

References

1. World Health Organization. Ending the Neglect to Attain the Sustainable Development Goals: A Road Map for Neglected Tropical Diseases 2021-2030. Geneva: WHO; 2020.
2. Hotez PJ, Aksoy S, Brindley PJ, Kamhawi S. What constitutes a neglected tropical disease? PLoS Negl Trop Dis. 2020;14(1):e0008001.
3. Molyneux DH, Savioli L, Engels D. Neglected tropical diseases: progress towards addressing the chronic pandemic. Lancet. 2017;389(10066):312-325.
4. Booth M. Climate change and the neglected tropical diseases. Adv Parasitol. 2018;100:39-126.

Read this lecture as Markdown